Defence Therapeutics Inc. (FRA:DTC)
Germany flag Germany · Delayed Price · Currency is EUR
0.4200
+0.0210 (5.26%)
Last updated: Jan 29, 2026, 3:28 PM CET

Defence Therapeutics Balance Sheet

Millions CAD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Equivalents
2.321.230.062.790.515.45
Cash & Short-Term Investments
2.321.230.062.790.515.45
Cash Growth
1669.07%2079.47%-97.97%451.20%-90.71%192.24%
Other Receivables
0.220.20.10.150.030.07
Receivables
0.220.20.10.150.030.07
Prepaid Expenses
0.030.030.060.490.140.04
Total Current Assets
2.581.460.213.430.675.56
Property, Plant & Equipment
0.190.190.260.06--
Other Intangible Assets
---0.040.050.05
Total Assets
2.771.650.483.530.725.61
Accounts Payable
1.131.332.090.190.980.11
Short-Term Debt
--0.05---
Current Portion of Long-Term Debt
1.561.491.66---
Current Portion of Leases
-0.020.03---
Other Current Liabilities
0.070.070.220.030.130.01
Total Current Liabilities
2.762.914.050.221.110.12
Long-Term Debt
---1.75--
Long-Term Leases
1.41-0.01---
Total Liabilities
4.182.914.061.971.110.12
Common Stock
24.1924.1919.2416.959.337.97
Retained Earnings
-30.02-29.31-29.81-16.91-10.52-3.53
Comprehensive Income & Other
4.423.866.981.520.791.05
Shareholders' Equity
-1.41-1.26-3.581.57-0.395.49
Total Liabilities & Equity
2.771.650.483.530.725.61
Total Debt
2.971.51.751.75--
Net Cash (Debt)
-0.65-0.27-1.691.050.515.45
Net Cash Growth
---106.61%-90.71%192.24%
Net Cash Per Share
-0.01-0.01-0.040.030.010.21
Filing Date Shares Outstanding
54.7354.7345.5444.2737.6835.96
Total Common Shares Outstanding
54.7354.7345.5443.7836.6335.22
Working Capital
-0.19-1.44-3.843.21-0.435.44
Book Value Per Share
-0.03-0.02-0.080.04-0.010.16
Tangible Book Value
-1.41-1.26-3.581.53-0.435.44
Tangible Book Value Per Share
-0.03-0.02-0.080.03-0.010.15
Machinery
0.290.270.270.07--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.